Lymphocyte expansion molecule
From Wikipedia, the free encyclopedia
Lymphocyte expansion molecule (LEXM) was considered to be a protein discovered in 2015, allegedly involved in immune responses (in mice) to some cancers and viruses.[1][2] The original paper however has since been retracted upon recommendation of Imperial College's investigators due to concerns about duplication of data.[3][4]
The protein was considered responsible for an increased production of T cells in mice. The protein was believed to be a potential target for drug discovery.[5][6] Scientists at Imperial College planned a gene therapy based on this protein.[1]
